ACTIVE SUBSTANCE / INN

VUTRISIRAN

Brand name(s): Amvuttra
EMA LISTED
AUTHORISED
Amyloid Neuropathies, Familial
ACTIVE SUBSTANCE
Vutrisiran
REGULATORS
EMA
SPONSORS / MAH
Alnylam Netherlands B.V.
TOTAL APPLICATIONS
1
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
AmvuttraAlnylam Netherlands B.V.Authorised15/09/2022Amyloid Neuropathies, Familial

FULL INTELLIGENCE ON VUTRISIRAN

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →